Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Sep;62(9):3916–3921. doi: 10.1128/iai.62.9.3916-3921.1994

Induced mouse spleen B-cell proliferation and secretion of immunoglobulin by lipid-associated membrane proteins of Mycoplasma fermentans incognitus and Mycoplasma penetrans.

S H Feng 1, S C Lo 1
PMCID: PMC303048  PMID: 8063408

Abstract

Mycoplasmas have been implicated as a possible cofactor in AIDS pathogenesis. Mycoplasma fermentans and M. penetrans infect human immunodeficiency virus-positive patients at a significantly higher frequency than non-human immunodeficiency virus-infected control subjects. Various mycoplasmal membrane preparations are known to affect the functions of immune cells both in vitro and in vivo. A group of lipid-associated membrane proteins (LAMPs) extracted by Triton X-114 from mycoplasmas are major antigenic targets of human host antibody responses. In this study, LAMPs prepared from both M. fermentans and M. penetrans nonspecifically stimulated spleen cells of CBA/CaH mice to proliferate. LAMPs were also stimulatory to spleen cells from athymic mice. On the other hand, enriched splenic T cells from CBA/CaH mice with or without accessory cells responded poorly. Thus, the mitogenic effect of mycoplasmal LAMPs appeared mainly on B cells. High levels of immunoglobulin (Ig) M and low but detectable amounts of IgG were found in the supernatant of LAMP-treated splenic cell culture. M. penetrans LAMPs had a much more potent effect on murine spleen cells than did M. fermentans incognitus LAMPs in inducing both B-cell proliferation and Ig secretion. In conclusion, the mycoplasmal LAMPs contained an active component(s) with T-independent B-cell mitogenic effect.

Full text

PDF
3916

Images in this article

3920Image
on p.3920

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biberfeld G. Activation of human lymphocyte subpopulations by Mycoplasma pneumoniae. Scand J Immunol. 1977;6(11):1145–1150. doi: 10.1111/j.1365-3083.1977.tb00353.x. [DOI] [PubMed] [Google Scholar]
  2. BiberfeldG, Nilsson E. Mitogenicity of Mycoplasma fermentans for human lymphocytes. Infect Immun. 1978 Jul;21(1):48–54. doi: 10.1128/iai.21.1.48-54.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem. 1981 Feb 25;256(4):1604–1607. [PubMed] [Google Scholar]
  4. Cole B. C., Atkin C. L. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol Today. 1991 Aug;12(8):271–276. doi: 10.1016/0167-5699(91)90125-D. [DOI] [PubMed] [Google Scholar]
  5. Dudler R., Schmidhauser C., Parish R. W., Wettenhall R. E., Schmidt T. A mycoplasma high-affinity transport system and the in vitro invasiveness of mouse sarcoma cells. EMBO J. 1988 Dec 1;7(12):3963–3970. doi: 10.1002/j.1460-2075.1988.tb03283.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Feng S. H., Rubinstein L. J., Stein K. E. A simple method for coating native polysaccharides onto nitrocellulose. J Immunol Methods. 1991 Mar 21;137(2):261–266. doi: 10.1016/0022-1759(91)90032-b. [DOI] [PubMed] [Google Scholar]
  7. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  8. Kaplan P. J., Garvey J. S. Mycoplasma neurolyticum membranes: a T-independent antigen in the rat. Immunol Invest. 1986 Mar;15(1):35–53. doi: 10.3109/08820138609042017. [DOI] [PubMed] [Google Scholar]
  9. Lo S. C., Dawson M. S., Wong D. M., Newton P. B., 3rd, Sonoda M. A., Engler W. F., Wang R. Y., Shih J. W., Alter H. J., Wear D. J. Identification of Mycoplasma incognitus infection in patients with AIDS: an immunohistochemical, in situ hybridization and ultrastructural study. Am J Trop Med Hyg. 1989 Nov;41(5):601–616. doi: 10.4269/ajtmh.1989.41.601. [DOI] [PubMed] [Google Scholar]
  10. Lo S. C., Hayes M. M., Wang R. Y., Pierce P. F., Kotani H., Shih J. W. Newly discovered mycoplasma isolated from patients infected with HIV. Lancet. 1991 Dec 7;338(8780):1415–1418. doi: 10.1016/0140-6736(91)92721-d. [DOI] [PubMed] [Google Scholar]
  11. Lo S. C., Shih J. W., Newton P. B., 3rd, Wong D. M., Hayes M. M., Benish J. R., Wear D. J., Wang R. Y. Virus-like infectious agent (VLIA) is a novel pathogenic mycoplasma: Mycoplasma incognitus. Am J Trop Med Hyg. 1989 Nov;41(5):586–600. doi: 10.4269/ajtmh.1989.41.586. [DOI] [PubMed] [Google Scholar]
  12. Loo V. G., Richardson S., Quinn P. Isolation of Mycoplasma pneumoniae from pleural fluid. Diagn Microbiol Infect Dis. 1991 Sep-Oct;14(5):443–445. doi: 10.1016/0732-8893(91)90071-m. [DOI] [PubMed] [Google Scholar]
  13. Mizushima Y., Quintans J., Cohen E. P. Stimulation of lymphoid cell proliferation by Mycoplasma orale, a common cell culture contaminant. Infect Immun. 1985 Dec;50(3):636–640. doi: 10.1128/iai.50.3.636-640.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Naot Y., Siman-Tov R., Ginsburg H. Mitogenic activity of Mycoplasma pulmonis. II. Studies on the biochemical nature of the mitogenic factor. Eur J Immunol. 1979 Feb;9(2):149–154. doi: 10.1002/eji.1830090211. [DOI] [PubMed] [Google Scholar]
  15. Naot Y., Tully J. G., Ginsburg H. Lymphocyte activation by various Mycoplasma strains and species. Infect Immun. 1977 Nov;18(2):310–317. doi: 10.1128/iai.18.2.310-317.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Razin S. The mycoplasmas. Microbiol Rev. 1978 Jun;42(2):414–470. doi: 10.1128/mr.42.2.414-470.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ruuth E., Praz F. Interactions between mycoplasmas and the immune system. Immunol Rev. 1989 Dec;112:133–160. doi: 10.1111/j.1600-065x.1989.tb00556.x. [DOI] [PubMed] [Google Scholar]
  18. Simecka J. W., Ross S. E., Cassell G. H., Davis J. K. Interactions of mycoplasmas with B cells: antibody production and nonspecific effects. Clin Infect Dis. 1993 Aug;17 (Suppl 1):S176–S182. doi: 10.1093/clinids/17.supplement_1.s176. [DOI] [PubMed] [Google Scholar]
  19. Sitia R., Rubartelli A., Deambrosis S., Pozzi D., Hämmerling U. Differentiation in the murine B cell lymphoma I.29: inductive capacities of lipopolysaccharide and Mycoplasma fermentans products. Eur J Immunol. 1985 Jun;15(6):570–575. doi: 10.1002/eji.1830150608. [DOI] [PubMed] [Google Scholar]
  20. Smith P. F. Antigenic character of membrane lipoglycans from Mollicutes--a review. Isr J Med Sci. 1987 May;23(5):448–452. [PubMed] [Google Scholar]
  21. Taylor-Robinson D. Genital mycoplasma infections. Clin Lab Med. 1989 Sep;9(3):501–523. [PubMed] [Google Scholar]
  22. Wang R. Y., Shih J. W., Grandinetti T., Pierce P. F., Hayes M. M., Wear D. J., Alter H. J., Lo S. C. High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients. Lancet. 1992 Nov 28;340(8831):1312–1316. doi: 10.1016/0140-6736(92)92493-y. [DOI] [PubMed] [Google Scholar]
  23. Wang R. Y., Shih J. W., Weiss S. H., Grandinetti T., Pierce P. F., Lange M., Alter H. J., Wear D. J., Davies C. L., Mayur R. K. Mycoplasma penetrans infection in male homosexuals with AIDS: high seroprevalence and association with Kaposi's sarcoma. Clin Infect Dis. 1993 Oct;17(4):724–729. doi: 10.1093/clinids/17.4.724. [DOI] [PubMed] [Google Scholar]
  24. Wise K. S., Kim M. F. Major membrane surface proteins of Mycoplasma hyopneumoniae selectively modified by covalently bound lipid. J Bacteriol. 1987 Dec;169(12):5546–5555. doi: 10.1128/jb.169.12.5546-5555.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wright K. Mycoplasmas in the AIDS spotlight. Science. 1990 May 11;248(4956):682–683. doi: 10.1126/science.2333519. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES